Vigo Heissmeyer
Impact in
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Cancer Research top 1%
- NF-κB Signaling Pathways
Papers in
-
- NF-κB Signaling Pathways 13
- MicroRNA in disease regulation 8
- Immunology 31
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 13
- Immune Response and Inflammation 9
- Co-authors
- Anjana RaoDaniel KrappmannClaus ScheidereitKai P. HoefigK. Mark AnselAriya D. LapanLin ChenJames C. Stroud
- Journals
- Nature Communications (7 papers)Nature Immunology (5 papers)Molecular and Cellular Biology (4 papers)Nature Structural & Molecular Biology (3 papers)The EMBO Journal (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Vigo Heissmeyer
63 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Immunology 3.0k
- Cancer Research 1.6k
- Oncology 1.2k
- Molecular Biology 2.7k
- Transplantation 37
Countries citing papers authored by Vigo Heissmeyer
This map shows the geographic impact of Vigo Heissmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vigo Heissmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vigo Heissmeyer more than expected).
Fields of papers citing papers by Vigo Heissmeyer
This network shows the impact of papers produced by Vigo Heissmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vigo Heissmeyer. The network helps show where Vigo Heissmeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Vigo Heissmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2022 | 64 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 26 | |
| 5 | 2021 | 36 | |
| 6 | 2018 | 41 | |
| 7 | 2018 | 26 | |
| 8 | 2018 | 28 | |
| 9 | 2016 | 105 | |
| 10 | 2016 | 41 | |
| 11 | 2015 | 60 | |
| 12 | The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells Hit paper breakdown → | 2015 | 532 |
| 13 | 2013 | 57 | |
| 14 | 2012 | 1 | |
| 15 | 2008 | 58 | |
| 16 | FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT Hit paper breakdown → | 2006 | 937 |
| 17 | 2006 | 40 | |
| 18 | 2006 | 112 | |
| 19 | 2004 | 436 | |
| 20 | 1999 | 176 |
About Vigo Heissmeyer
Vigo Heissmeyer is a scholar working on Cancer Research, Immunology, Molecular Biology, Immunology and Allergy and Oncology, having authored 64 papers that have together received 5.4k indexed citations. Recurring topics across this work include RNA Research and Splicing (20 papers), Immune Cell Function and Interaction (18 papers), RNA modifications and cancer (17 papers), RNA and protein synthesis mechanisms (15 papers), T-cell and B-cell Immunology (13 papers), NF-κB Signaling Pathways (13 papers), Immune Response and Inflammation (9 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Immunology (3.0k citations), Cancer Research (1.6k citations), Oncology (1.2k citations), Molecular Biology (2.7k citations) and Transplantation (37 citations). Vigo Heissmeyer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Anjana Rao, Daniel Krappmann, Claus Scheidereit, Kai P. Hoefig, K. Mark Ansel, Ariya D. Lapan, Lin Chen, James C. Stroud, Liang Guo and Christophe Benoıst. Their work appears in journals such as Nature Communications, Nature Immunology, Molecular and Cellular Biology, Nature Structural & Molecular Biology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.